Insider Trading activities of Seattle Genetics Inc /wa insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Seattle Genetics Inc /wa since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Seattle Genetics Inc /wa since year 2005. Table 2 shows the detailed insider transactions of Seattle Genetics Inc /wa since 2005. The reporting company's ticker symbol is SGEN. The reporting company's CIK number is 1060736.
The total value of stock buying since 2005 is $1,202,514,629.
The total value of stock sales since 2005 is $248,686,406.
The total value of stock option exercises since 2005 is $46,022,989.


 1   2   3   4 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Seattle Genetics Inc /wa (SGEN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 18,832 $1,140,710 36,648 $409,935
2017-09 0 $0 43,494 $2,305,871 47,897 $575,908
2017-08 0 $0 111,435 $5,495,429 54,320 $760,971
2017-07 0 $0 20,423 $1,088,867 20,423 $210,151
2017-06 0 $0 20,423 $1,325,554 20,423 $210,151
2017-05 0 $0 14,462 $903,629 34,462 $352,481
2017-04 0 $0 14,465 $907,678 14,465 $147,976
2017-03 0 $0 24,465 $1,609,703 24,465 $240,276
2017-02 0 $0 14,465 $893,604 14,465 $148,410
2017-01 0 $0 14,465 $836,337 19,465 $199,773
2016-12 0 $0 66,965 $4,388,040 88,458 $1,295,857
2016-11 1,990,898 $113,028,613 26,634 $1,589,035 22,216 $234,151
2016-10 0 $0 14,465 $787,026 14,465 $148,193
2016-09 861,327 $42,584,534 73,486 $3,712,535 94,560 $976,028
2016-08 0 $0 66,788 $3,135,680 15,491 $185,398
2016-07 0 $0 11,660 $490,789 11,660 $75,128
2016-06 0 $0 25,449 $1,103,839 27,083 $235,024
2016-05 0 $0 64,678 $2,571,014 64,678 $618,636
2016-04 0 $0 8,418 $307,162 8,418 $42,059
2016-03 3,094,691 $94,640,589 15,236 $543,281 60,236 $396,899
2016-02 253,722 $7,720,336 0 $0 0 $0
2015-12 0 $0 44,220 $1,766,251 79,256 $766,665
2015-11 1,263,982 $54,492,142 124,412 $5,572,313 3,718 $20,932
2015-10 0 $0 3,718 $153,542 35,983 $183,547
2015-09 5,159,484 $223,511,111 3,718 $149,166 18,519 $224,149
2015-08 0 $0 84,093 $3,552,128 18,517 $287,164
2015-07 0 $0 3,718 $174,515 3,718 $20,932
2015-06 0 $0 3,718 $169,972 3,718 $20,932
2015-05 1,983,550 $76,782,907 69,126 $2,805,448 72,052 $395,252
2015-04 0 $0 0 $0 5,000 $41,900
2015-03 733,877 $25,514,852 27,500 $1,022,875 20,000 $184,600
2015-02 281,115 $9,554,251 0 $0 0 $0
2015-01 0 $0 16,804 $534,316 16,804 $99,479
2014-12 4,131,274 $133,482,472 0 $0 0 $0
2014-11 1,653,925 $57,474,581 10,000 $375,170 10,000 $92,300
2014-09 0 $0 5,600 $238,224 5,600 $33,152
2014-08 0 $0 52,551 $2,253,010 19,533 $166,300
2014-06 1,044,810 $39,337,333 11,200 $449,579 11,200 $66,304
2014-05 189,611 $6,460,736 10,000 $350,000 40,000 $310,100
2014-04 0 $0 5,600 $242,704 5,600 $33,152
2014-03 0 $0 9,318 $492,801 9,318 $53,811
2014-02 0 $0 107,781 $5,607,534 33,942 $353,115
2014-01 0 $0 59,069 $2,812,348 1,858 $19,193
2013-12 1,412,979 $59,616,278 2,000 $82,492 20,996 $133,116
2013-11 0 $0 2,000 $77,254 2,000 $20,660
2013-10 0 $0 2,000 $87,732 2,000 $20,660
2013-09 0 $0 229,000 $9,992,915 135,223 $2,064,226
2013-08 0 $0 56,034 $2,310,908 80,129 $1,181,230
2013-07 0 $0 94,527 $3,530,660 94,527 $1,216,805
2013-06 0 $0 17,000 $552,612 17,000 $154,860
2013-05 488,382 $16,625,602 19,500 $723,574 19,500 $243,960
2013-04 0 $0 2,000 $71,062 2,000 $20,660
2013-03 0 $0 313,968 $9,397,988 180,676 $2,195,555
2013-02 0 $0 12,000 $330,916 12,000 $87,560
2013-01 0 $0 191,601 $5,193,121 200,618 $2,321,384
2012-12 0 $0 242,338 $6,110,357 257,875 $2,525,778
2012-11 0 $0 115,577 $2,877,754 220,373 $1,975,499
2012-10 0 $0 33,250 $844,642 33,250 $313,472
2012-09 0 $0 161,790 $4,658,070 161,790 $1,679,617
2012-08 0 $0 118,250 $3,067,211 120,750 $1,181,962
2012-07 0 $0 8,250 $209,203 11,250 $113,283
2012-06 0 $0 186,566 $4,468,470 178,566 $1,186,492
2012-05 0 $0 65,949 $1,403,142 65,949 $297,069
2012-04 0 $0 147,500 $2,870,466 147,500 $1,058,733
2012-03 0 $0 149,626 $2,875,258 157,126 $1,208,365
2012-02 0 $0 46,000 $851,920 46,000 $472,190
2012-01 0 $0 55,000 $1,040,965 55,000 $424,700
2011-12 0 $0 25,000 $420,515 36,375 $206,100
2011-11 0 $0 15,000 $328,410 17,516 $108,309
2011-10 0 $0 80,729 $1,717,424 80,729 $482,311
2011-09 260,147 $4,451,895 30,000 $603,713 71,251 $489,328
2011-08 1,201,287 $18,415,872 0 $0 0 $0
2011-07 0 $0 15,000 $309,870 33,663 $185,148
2011-06 7,000 $140,273 40,238 $803,586 23,253 $135,169
2011-05 0 $0 293,960 $5,280,868 298,960 $2,151,861
2011-04 0 $0 179,415 $2,872,409 177,499 $1,288,021
2011-03 0 $0 200,000 $2,817,200 200,000 $1,686,000
2011-02 1,848,197 $28,647,052 0 $0 0 $0
2010-12 0 $0 50,000 $800,650 54,000 $357,000
2010-11 0 $0 25,000 $367,400 29,000 $188,000
2010-10 0 $0 25,000 $423,750 30,000 $247,900
2010-09 0 $0 25,000 $373,750 25,000 $206,000
2010-08 0 $0 0 $0 61,332 $245,161
2010-06 652,141 $7,790,044 0 $0 50,000 $368,300
2010-05 619,778 $7,898,117 25,000 $323,750 40,203 $310,702
2010-04 620,491 $7,835,558 0 $0 30,000 $90,000
2010-03 24,500 $293,244 0 $0 0 $0
2010-02 0 $0 0 $0 4,000 $16,720
2009-12 0 $0 0 $0 20,405 $103,749
2009-10 0 $0 0 $0 11,985 $54,777
2009-09 0 $0 0 $0 10,000 $30,000
2009-08 3,721,771 $40,012,568 0 $0 0 $0
2009-07 0 $0 110,000 $1,348,780 112,000 $676,625
2009-06 5,500 $50,638 0 $0 0 $0
2009-05 2,352,616 $22,867,425 0 $0 0 $0
2008-12 0 $0 0 $0 5,000 $26,250
2008-09 0 $0 143,187 $1,777,407 47,309 $270,476
2008-08 0 $0 50,000 $564,950 65,000 $381,000
2008-07 0 $0 708,190 $7,627,094 0 $0
2008-05 0 $0 761,936 $7,709,540 0 $0
2008-03 701,140 $5,601,554 0 $0 0 $0
2008-02 388,136 $3,491,677 0 $0 0 $0
2008-01 5,510,589 $49,562,123 0 $0 6,000 $25,080
2007-12 0 $0 42,184 $532,783 25,000 $28,250
2007-09 2,000 $21,240 234,350 $2,739,696 254,979 $1,309,124
2007-08 0 $0 257,332 $2,853,018 216,668 $650,004
2007-05 0 $0 84,891 $872,132 84,891 $418,344
2007-04 0 $0 25,000 $238,499 25,000 $168,000
2007-02 0 $0 8,398,938 $72,743,060 43,472 $185,060
2007-01 0 $0 25,000 $130,475 0 $0
2006-12 0 $0 300,000 $1,711,150 0 $0
2006-11 0 $0 150,000 $828,600 0 $0
2006-10 0 $0 100,000 $495,389 0 $0
2006-08 1,058,406 $4,258,455 0 $0 0 $0
2006-06 5,533,082 $22,381,874 0 $0 0 $0
2006-05 1,979,380 $10,391,742 0 $0 0 $0
2005-09 0 $0 97,000 $578,922 0 $0
2005-08 0 $0 103,000 $612,953 0 $0
2005-05 49,052 $234,950 76,500 $392,292 0 $0
2005-04 607,103 $2,425,976 0 $0 0 $0
2005-03 989,701 $4,916,015 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Seattle Genetics Inc /wa insiders (SGEN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-11 Siegall Clay B (President and CEO) Sale 18,832 60.57 1,140,710
2017-10-11 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2017-10-05 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 17,816 11.29 201,089
2017-09-26 Siegall Clay B (President and CEO) Option Ex 9,017 11.09 99,998
2017-09-11 Siegall Clay B (President and CEO) Sale 18,832 53.78 1,012,879
2017-09-11 Siegall Clay B (President and CEO) Option Ex 18,832 11.09 208,846
2017-09-08 Himes Vaughn B (Chief Technical Officer) Sale 10,000 53.09 530,850
2017-09-08 Himes Vaughn B (Chief Technical Officer) Option Ex 10,000 10.70 106,950
2017-09-06 Cline Darren S (EVP, Commercial) Sale 5,024 51.94 260,966
2017-09-06 Cline Darren S (EVP, Commercial) Option Ex 10,048 15.94 160,114
2017-09-06 Simpson Todd E (Chief Financial Officer) Sale 9,638 52.00 501,176
2017-08-31 Cline Darren S (EVP, Commercial) Sale 7,569 52.51 397,478
2017-08-31 Cline Darren S (EVP, Commercial) Option Ex 2,907 18.46 53,663
2017-08-31 Dobmeier Eric (Chief Operating Officer) Sale 25,000 52.24 1,305,900
2017-08-31 Dobmeier Eric (Chief Operating Officer) Option Ex 25,000 15.46 386,500
2017-08-28 Cline Darren S (EVP, Commercial) Sale 1,788 47.90 85,636
2017-08-28 Drachman Jonathan G (CMO & EVP, R & D) Sale 8,502 47.90 407,203
2017-08-28 Himes Vaughn B (Chief Technical Officer) Sale 6,377 47.90 305,426
2017-08-28 Simpson Todd E (Chief Financial Officer) Sale 4,937 47.90 236,457
2017-08-28 Dobmeier Eric (Chief Operating Officer) Sale 5,343 47.90 255,902
2017-08-28 Siegall Clay B (President and CEO) Sale 25,506 47.90 1,221,609
2017-08-24 Drachman Jonathan G (CMO & EVP, R & D) Sale 10,000 47.54 475,409
2017-08-24 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 10,000 10.29 102,899
2017-08-07 Cline Darren S (EVP, Commercial) Sale 6,000 49.19 295,110
2017-08-07 Cline Darren S (EVP, Commercial) Option Ex 6,000 18.46 110,760
2017-08-07 Siegall Clay B (President and CEO) Sale 10,413 48.91 509,299
2017-08-07 Siegall Clay B (President and CEO) Option Ex 10,413 10.29 107,149
2017-07-27 Drachman Jonathan G (CMO & EVP, R & D) Sale 10,000 54.54 545,360
2017-07-27 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 10,000 10.29 102,899
2017-07-05 Siegall Clay B (President and CEO) Sale 10,423 52.15 543,507
2017-07-05 Siegall Clay B (President and CEO) Option Ex 10,423 10.29 107,252
2017-06-22 Drachman Jonathan G (CMO & EVP, R & D) Sale 10,000 64.29 642,900
2017-06-22 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 10,000 10.29 102,899
2017-06-05 Siegall Clay B (President and CEO) Sale 10,423 65.50 682,654
2017-06-05 Siegall Clay B (President and CEO) Option Ex 10,423 10.29 107,252
2017-05-15 Baker Brothers Life Sciences Lp (Director) Option Ex 20,000 10.20 204,000
2017-05-05 Siegall Clay B (President and CEO) Sale 14,462 62.48 903,629
2017-05-05 Siegall Clay B (President and CEO) Option Ex 14,462 10.27 148,481
2017-04-05 Siegall Clay B (President and CEO) Sale 14,465 62.75 907,678
2017-04-05 Siegall Clay B (President and CEO) Option Ex 14,465 10.23 147,976
2017-03-31 Himes Vaughn B (Chief Technical Officer) Sale 10,000 62.75 627,530
2017-03-31 Himes Vaughn B (Chief Technical Officer) Option Ex 10,000 9.23 92,300
2017-03-06 Siegall Clay B (President and CEO) Sale 14,465 67.90 982,173
2017-03-06 Siegall Clay B (President and CEO) Option Ex 14,465 10.23 147,976
2017-02-06 Siegall Clay B (President and CEO) Sale 14,465 61.78 893,604
2017-02-06 Siegall Clay B (President and CEO) Option Ex 14,465 10.26 148,410
2017-01-25 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 5,000 10.29 51,449
2017-01-06 Siegall Clay B (President and CEO) Sale 14,465 57.82 836,337
2017-01-06 Siegall Clay B (President and CEO) Option Ex 14,465 10.25 148,324
2016-12-16 Cline Darren S (EVP, Commercial) Option Ex 3,100 16.41 50,871
2016-12-13 Cline Darren S (EVP, Commercial) Sale 10,000 63.80 638,010
2016-12-13 Cline Darren S (EVP, Commercial) Option Ex 12,761 22.28 284,315
2016-12-12 Himes Vaughn B (Chief Technical Officer) Option Ex 15,632 17.85 279,078
2016-12-08 Dobmeier Eric (Chief Operating Officer) Sale 12,500 65.95 824,400
2016-12-08 Dobmeier Eric (Chief Operating Officer) Option Ex 12,500 20.52 256,500
2016-12-07 Himes Vaughn B (Chief Technical Officer) Sale 30,000 65.69 1,970,550
2016-12-07 Himes Vaughn B (Chief Technical Officer) Option Ex 30,000 9.23 276,900
2016-12-06 Siegall Clay B (President and CEO) Sale 14,465 66.03 955,080
2016-12-06 Siegall Clay B (President and CEO) Option Ex 14,465 10.24 148,193
2016-11-09 Drachman Jonathan G (CMO & EVP, R & D) Sale 7,751 66.75 517,379
2016-11-09 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 7,751 11.09 85,958
2016-11-08 Baker Brothers Life Sciences Lp (Director) Buy 326,300 59.47 19,403,429
2016-11-07 Baker Brothers Life Sciences Lp (Director) Buy 56,200 58.74 3,301,356
2016-11-07 Lippman Marc E (Director) Sale 1,000 57.75 57,749
2016-11-07 Siegall Clay B (President and CEO) Sale 14,465 57.87 837,060
2016-11-07 Siegall Clay B (President and CEO) Option Ex 14,465 10.24 148,193
2016-11-03 Baker Brothers Life Sciences Lp (Director) Buy 577,769 56.54 32,700,636
2016-11-02 Baker Brothers Life Sciences Lp (Director) Buy 466,619 56.04 26,151,195
2016-11-01 Drachman Jonathan G (CMO & EVP, R & D) Sale 3,418 51.74 176,847
2016-11-01 Baker Brothers Life Sciences Lp (Director) Buy 184,674 53.89 9,952,266
2016-10-06 Siegall Clay B (President and CEO) Sale 14,465 54.41 787,026
2016-10-06 Siegall Clay B (President and CEO) Option Ex 14,465 10.24 148,193
2016-09-22 Drachman Jonathan G (CMO & EVP, R & D) Sale 2,249 56.75 127,630
2016-09-22 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 2,249 10.29 23,142
2016-09-14 Dobmeier Eric (Chief Operating Officer) Sale 22,918 54.22 1,242,705
2016-09-14 Dobmeier Eric (Chief Operating Officer) Option Ex 22,918 12.00 275,016
2016-09-13 Baker Brothers Life Sciences Lp (Director) Buy 141,202 50.74 7,164,024
2016-09-12 Baker Brothers Life Sciences Lp (Director) Buy 49,889 50.64 2,526,378
2016-09-09 Cline Darren S (EVP, Commercial) Option Ex 4,167 15.46 64,421
2016-09-09 Baker Brothers Life Sciences Lp (Director) Buy 256,220 50.58 12,958,326
2016-09-08 Baker Brothers Life Sciences Lp (Director) Buy 211,093 49.85 10,523,830
2016-09-08 Siegall Clay B (President and CEO) Sale 31,269 50.08 1,565,982
2016-09-08 Siegall Clay B (President and CEO) Option Ex 31,269 10.29 321,758
2016-09-07 Baker Brothers Life Sciences Lp (Director) Buy 59,560 48.29 2,875,914
2016-09-06 Cline Darren S (EVP, Commercial) Sale 5,397 46.01 248,326
2016-09-06 Baker Brothers Life Sciences Lp (Director) Buy 143,363 45.59 6,536,062
2016-09-06 Gryska David W (Director) Option Ex 10,000 10.20 102,000
2016-09-06 Siegall Clay B (President and CEO) Sale 11,653 45.30 527,892
2016-09-06 Siegall Clay B (President and CEO) Option Ex 23,957 7.92 189,691
2016-08-23 Dobmeier Eric (Chief Operating Officer) Sale 12,589 48.00 604,272
2016-08-23 Dobmeier Eric (Chief Operating Officer) Option Ex 3,831 26.10 99,989
2016-08-22 Cline Darren S (EVP, Commercial) Sale 1,774 46.59 82,652
2016-08-22 Drachman Jonathan G (CMO & EVP, R & D) Sale 3,991 46.59 185,944
2016-08-22 Himes Vaughn B (EVP, Proc Svcs & Tech Ops) Sale 3,991 46.59 185,944
2016-08-22 Simpson Todd E (Chief Financial Officer) Sale 3,991 46.59 185,944
2016-08-22 Dobmeier Eric (Chief Operating Officer) Sale 5,411 46.59 252,103
2016-08-22 Siegall Clay B (President and CEO) Sale 23,381 46.59 1,089,344
2016-08-08 Siegall Clay B (President and CEO) Sale 11,660 47.12 549,477
2016-08-08 Siegall Clay B (President and CEO) Option Ex 11,660 7.33 85,409
2016-07-27 Siegall Clay B (President and CEO) Sale 4,042 45.20 182,718
2016-07-27 Siegall Clay B (President and CEO) Option Ex 4,042 10.20 41,228
2016-07-06 Siegall Clay B (President and CEO) Sale 7,618 40.44 308,071
2016-07-06 Siegall Clay B (President and CEO) Option Ex 7,618 4.45 33,900
2016-06-06 Siegall Clay B (President and CEO) Sale 22,083 43.57 962,222
2016-06-06 Siegall Clay B (President and CEO) Option Ex 22,083 8.31 183,575
2016-06-02 Cline Darren S (EVP, Commercial) Sale 3,366 42.07 141,617
2016-06-02 Drachman Jonathan G (CMO & EVP, R & D) Option Ex 5,000 10.29 51,449
2016-05-27 Siegall Clay B (President and CEO) Sale 10,792 40.10 432,813
2016-05-27 Siegall Clay B (President and CEO) Option Ex 10,792 10.29 111,049
2016-05-26 Siegall Clay B (President and CEO) Sale 1,130 40.07 45,283
2016-05-26 Siegall Clay B (President and CEO) Option Ex 1,130 10.29 11,627
2016-05-25 Siegall Clay B (President and CEO) Sale 36,738 40.51 1,488,293
2016-05-25 Siegall Clay B (President and CEO) Option Ex 36,738 10.24 376,380
2016-05-24 Siegall Clay B (President and CEO) Sale 1,700 40.00 68,000
2016-05-24 Siegall Clay B (President and CEO) Option Ex 1,700 10.20 17,340
2016-05-23 Siegall Clay B (President and CEO) Sale 6,700 40.12 268,777
2016-05-23 Siegall Clay B (President and CEO) Option Ex 6,700 10.20 68,340
2016-05-17 Siegall Clay B (President and CEO) Sale 7,618 35.16 267,848
2016-05-17 Siegall Clay B (President and CEO) Option Ex 7,618 4.45 33,900
2016-04-25 Siegall Clay B (President and CEO) Sale 800 40.00 32,000
2016-04-25 Siegall Clay B (President and CEO) Option Ex 800 10.20 8,159
2016-04-05 Siegall Clay B (President and CEO) Sale 7,618 36.12 275,162
2016-04-05 Siegall Clay B (President and CEO) Option Ex 7,618 4.45 33,900
2016-03-22 Siegall Clay B (President and CEO) Sale 10,954 35.91 393,369
2016-03-22 Siegall Clay B (President and CEO) Option Ex 10,954 4.45 48,745
2016-03-21 Siegall Clay B (President and CEO) Sale 4,282 35.01 149,912
2016-03-21 Siegall Clay B (President and CEO) Option Ex 4,282 4.45 19,054
2016-03-17 Baker Brothers Life Sciences Lp (Director) Buy 124,065 32.07 3,978,392
2016-03-16 Baker Brothers Life Sciences Lp (Director) Buy 569,203 31.71 18,050,565
2016-03-15 Baker Brothers Life Sciences Lp (Director) Buy 661,093 31.85 21,057,134
2016-03-14 Baker Brothers Life Sciences Lp (Director) Buy 118,941 33.77 4,016,518
2016-03-11 Baker Brothers Life Sciences Lp (Director) Buy 195,765 32.82 6,424,811
2016-03-10 Baker Brothers Life Sciences Lp (Director) Buy 290,231 32.35 9,390,424
2016-03-09 Baker Brothers Life Sciences Lp (Director) Buy 208,670 31.91 6,659,494
2016-03-08 Baker Brothers Life Sciences Lp (Director) Buy 153,200 .00 0
2016-03-08 Baker Brothers Life Sciences Lp (Director) Option Ex 20,000 4.18 83,600
2016-03-08 Welch Daniel G (Director) Option Ex 25,000 9.82 245,500
2016-03-07 Baker Brothers Life Sciences Lp (Director) Buy 61,265 33.70 2,064,630
2016-03-04 Baker Brothers Life Sciences Lp (Director) Buy 288,058 32.09 9,242,917
2016-03-02 Baker Brothers Life Sciences Lp (Director) Buy 400,000 32.50 12,999,600
2016-03-01 Baker Brothers Life Sciences Lp (Director) Buy 24,200 31.24 756,104
2016-02-29 Baker Brothers Life Sciences Lp (Director) Buy 251,722 30.45 7,663,676
2016-02-12 Orwin John A (Director) Buy 2,000 28.33 56,660
2015-12-18 Himes Vaughn B (EVP, Proc Svcs & Tech Ops) Option Ex 35,036 10.62 371,907
2015-12-15 Himes Vaughn B (EVP, Proc Svcs & Tech Ops) Sale 40,500 39.94 1,617,489
2015-12-15 Himes Vaughn B (EVP, Proc Svcs & Tech Ops) Option Ex 40,500 9.23 373,815
2015-12-03 Siegall Clay B (President and CEO) Sale 3,720 39.99 148,762
2015-12-03 Siegall Clay B (President and CEO) Option Ex 3,720 5.63 20,943
2015-11-20 Baker Brothers Life Sciences Lp (Director) Buy 181,647 43.93 7,980,297
2015-11-19 Baker Brothers Life Sciences Lp (Director) Buy 133,073 43.93 5,845,364
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of SGEN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Seattle Genetics Inc /wa (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.